Treatment strategies and risk of central nervous system recurrence in high-grade B-cell and Burkitt lymphoma

Leuk Lymphoma. 2020 Jan;61(1):198-201. doi: 10.1080/10428194.2019.1654097. Epub 2019 Aug 21.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • B-Lymphocytes
  • Burkitt Lymphoma* / diagnosis
  • Burkitt Lymphoma* / epidemiology
  • Burkitt Lymphoma* / therapy
  • Central Nervous System
  • Humans
  • Lymphoma, Large B-Cell, Diffuse*
  • Neoplasm Recurrence, Local